placeholder image
T. Tokito All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
    New England Journal of Medicine. 2018
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 
    New England Journal of Medicine. 2017
    • Contact
    full name
  • T. Tokito
    • Quick Info
     
    Collaboration